GAINESVILLE, Fla., January 20, 2026--neuropacs™ Corp., a leading innovator in AI-driven neurological diagnostics, announced today the successful raise of over $1.0 million in early-stage capital.
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...
Discover how AI is revolutionizing veterinary radiology, and learn how algorithms support specialists for faster, more ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical device industry is changing ...
A deep learning algorithm called FaceAge could allow clinicians to improve their qualitative assessments, and possibly catch ...
RetinalGenix Technologies Inc. [OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...
Brain–computer interfaces have long been associated with medical labs, invasive implants, and distant promises. At CES 2026, ...
In this scenario, Series 12 becomes a polished evolution rather than a redesign. It would align with Apple’s recent message ...
I asked her if she knew if the AMH test was accurate. Many such online-marketed tests aren't. But they are ubiquitous on ...
Patero, a pioneer in post-quantum cryptography (PQC), today announced the launch of its Cryptographic Inventory Workshop, a facilitated, pre-inventory engagement designed to help organizations rapidly ...
Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...
TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback